AVECHO BIOTECHNOLOGY LIMITED (AVE)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for AVE during the last 90 days, indicating Moderate trading activity

Latest AVE Signals
18/06/2026	BUY
AVE Share Price
Current Price	$0.023
52 Week High	$0.024
52 Week Low:	$0.004
Trading at (% of 52 Week High)	95.83%

Business Overview

Avecho Biotechnology Limited (ASX: AVE) is an Australian company focused on developing innovative cancer therapies. It specializes in RNA products and immunotherapies aimed at improving treatment outcomes for cancer patients. The company leverages its proprietary technology to create targeted medicines.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for AVECHO BIOTECHNOLOGY LIMITED is supported by potential upside at a low entry price, but overall confidence is low due to limited market capitalization, low liquidity, and inherent risks in the biotechnology sector.

Latest  AVECHO BIOTECHNOLOGY LIMITED(AVE)   News